COMPANY
Limax Biosciences
Funding and NIH signals
- NIH award NIH awarded $1.05M (SBIR Phase II 1R44HL184761-01, new, notice Sep 9, 2026). NIH RePORTER 1R44HL184761-01 (Sep 9, 2026)
Evidence (1 event)
- Sep 9, 2026 · NIH RePORTER 1R44HL184761-01
Organization: LIMAX BIOSCIENCES INC; City/State: SOMERVILLE, MA; Project number: 1R44HL184761-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-09; FY total cost (award amount): 1047908; Administering IC: National Heart Lung and Blood Institute; Project title: Advanced Hemostatic Adhesive Hydrogel System for Postpartum Hemorrhage Control; Organization type: Domestic For-Profits
- Sep 9, 2026 · NIH RePORTER 1R44HL184761-01